BRIEF-Galectin Therapeutics has says can cover expenditures through 2017 - SEC filing
* Has generated sufficient financing to cover currently planned expenditures through 2017 - sec filing [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: filing, through, expenditures, cover, currently planned, financing, sufficient, generated, Therapeutics, BRIEF-Galectin
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/kKwi37tL9xE/idUSFWN1FM0R0